Tuesday, January 26, 2016

The US Has a Drug Problem with Kyle Bass, Hayman Capital Management L.P.

A small minority of drug companies are abusing the drug patent system in the U.S to sustain patents that contain no meaningful innovations, but serve to maintain their anti-competitive, high-price monopoly to the detriment of Americans suffering from illness. Kyle Bass will share his views on inefficient regulation and how eliminating improperly granted pharmaceutical patents promotes competition and innovation, which ultimately benefits consumers and taxpayers.

5:00 p.m. reception
5:30 p.m. lecture

Harper Center Room 104
5807 S Woodlawn Ave
Chicago, IL 60637

Free and open to the public


Support The Stigler Center
Pro-Market | The Stigler Center Blog
Financial Trust Index, How much do Americans trust financial institutions?
Sign Up for the Stigler Newsletter

Connect

Twitter

Facebook